These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2347017)

  • 1. Membrane permeation-controlled transdermal delivery system design. Influence of controlling membrane and adhesive on skin permeation of isosorbide dinitrate.
    Seki T; Kawaguchi T; Sugibayashi K; Juni K; Morimoto Y
    Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):740-3. PubMed ID: 2347017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on transdermal delivery system of isosorbide dinitrate].
    Ji AM; Jiang XT; Wang XF; Zou HQ
    Yao Xue Xue Bao; 1992; 27(11):858-63. PubMed ID: 1300032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of isosorbide dinitrate concentration on its skin permeability from adhesive matrix devices.
    Hatanaka T; Oguchi M; Sugibayashi K; Morimoto Y
    Chem Pharm Bull (Tokyo); 1991 Jul; 39(7):1802-5. PubMed ID: 1777935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a membrane-controlled transdermal therapeutic system containing isosorbide dinitrate.
    Ocak F; Ağabeyoğlu I
    Int J Pharm; 1999 Apr; 180(2):177-83. PubMed ID: 10370188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of penetration enhancers on isosorbide dinitrate penetration through rat skin from a transdermal therapeutic system.
    Gabiga H; Cal K; Janicki S
    Int J Pharm; 2000 Apr; 199(1):1-6. PubMed ID: 10794921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel transdermal patch incorporating isosorbide dinitrate with bisoprolol: in vitro and in vivo characterization.
    Zhao JH; Fu JH; Wang SM; Su CH; Shan Y; Kong SJ; Wang Y; Lu WL; Zhang H; Zhang S; Li L; Zhang EH; Wang L; Pei QL; Wang JC; Zhang X; Zhang Q
    Int J Pharm; 2007 Jun; 337(1-2):88-101. PubMed ID: 17267147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electron beam irradiation: a novel technology for the development of transdermal system of isosorbide dinitrate.
    Kotiyan PN; Vavia PR; Bhardwaj YK; Sabarwal S; Majali AB
    Int J Pharm; 2004 Feb; 270(1-2):47-54. PubMed ID: 14726121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal delivery of isosorbide 5-mononitrate from a new membrane reservoir and matrix-type patches.
    Arra GS; Arutla S; Krishna DR
    Drug Dev Ind Pharm; 1998 May; 24(5):489-92. PubMed ID: 9876613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of external heating on the permeation of oxybutynin through human epidermal membrane.
    Mizushima H; Inoue K; Ishizuka H
    Biol Pharm Bull; 2007 Mar; 30(3):612-5. PubMed ID: 17329869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Concentration-time profile of isosorbide dinitrate and its metabolites in plasma following percutaneous resorption of a transdermal therapeutic system].
    Menke G; Schnellhammer R; Rietbrock N
    Arzneimittelforschung; 1987 Nov; 37(11):1301-3. PubMed ID: 3440041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of vehicles and pressure sensitive adhesives on the penetration of isosorbide dinitrate across the hairless mouse skin.
    Myoung Y; Choi HK
    Drug Deliv; 2002; 9(2):121-6. PubMed ID: 12055040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability and metabolism of isosorbide dinitrate from a transdermal spray.
    Laufen H; Leitold M
    Arzneimittelforschung; 1992 Jul; 42(7):931-5. PubMed ID: 1418058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous pharmacodynamics of transdermally delivered isosorbide dinitrate.
    Hori M; Ohtsuka S; Sunami M; Guy RH; Maibach HI
    Pharm Res; 1990 Dec; 7(12):1298-301. PubMed ID: 2095569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemodynamic effects of a transdermal formulation of isosorbide dinitrate and its pharmacokinetics in conscious dogs].
    Kogi K; Tanaka O; Kimura T; Saito T
    Nihon Yakurigaku Zasshi; 1982 Oct; 80(4):279-88. PubMed ID: 7152395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difference in the enhancing effects of ultrasound on the skin permeation of polar and non-polar drugs.
    Ueda H; Ogihara M; Sugibayashi K; Morimoto Y
    Chem Pharm Bull (Tokyo); 1996 Oct; 44(10):1973-6. PubMed ID: 8904829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of isosorbide dinitrate tape on exercise tolerance of patients with angina pectoris.
    Saito M; Nobuyoshi M; Nakamura N; Nishiyama S; Haze K; Hiramori K; Ikeda M
    Arzneimittelforschung; 1983; 33(9):1301-5. PubMed ID: 6685512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: formulation design and biopharmaceutical evaluation.
    Yang Z; Teng Y; Wang H; Hou H
    Int J Pharm; 2013 Apr; 447(1-2):231-40. PubMed ID: 23467076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous absorption enhancer applied to membrane permeation-controlled transdermal delivery of nicardipine hydrochloride.
    Seki T; Sugibayashi K; Juni K; Morimoto Y
    Drug Des Deliv; 1989 Jan; 4(1):69-75. PubMed ID: 2775447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro-in vivo correlation of percutaneous absorption: isosorbide dinitrate and morphine hydrochloride.
    Hatanaka T; Katayama K; Koizumi T; Sugibayashi K; Morimoto Y
    Biol Pharm Bull; 1994 Jun; 17(6):826-30. PubMed ID: 7951147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effect of liposomalization and addition of glycerol on the transdermal delivery of isosorbide 5-nitrate in rat skin.
    Barichello JM; Yamakawa N; Kisyuku M; Handa H; Shibata T; Ishida T; Kiwada H
    Int J Pharm; 2008 Jun; 357(1-2):199-205. PubMed ID: 18343610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.